Figure 1.
Figure 1. p38 MAPK is activated in low-grade MDS. Bone marrow (BM) biopsies from patients with MDS and control subjects with non-MDS causes of cytopenias were fixed and immunostained with antibody against phosphor-p38 MAPK (A). Histologic examination of 6 representative samples of low- and high-grade MDS and controls revealed more intense staining in low-grade MDS samples. The quantification of p-p38 staining was analyzed by counting the total number of positively stained cells (B) and by measuring intensity of the positively stained cells (C) in 5 hot fields (defined as area of high density of p-p38 staining) and aided by Image Pro Plus software. Error bars indicate SEM. Two-tailed t test shows significantly higher p38 activation per hot field in low-grade MDS samples. Differences in total p38 MAPK protein expression in 5 representative samples from each group were also evaluated in MDS and control bone marrows by immunostaining with an antibody against p38 MAPK (D).

p38 MAPK is activated in low-grade MDS. Bone marrow (BM) biopsies from patients with MDS and control subjects with non-MDS causes of cytopenias were fixed and immunostained with antibody against phosphor-p38 MAPK (A). Histologic examination of 6 representative samples of low- and high-grade MDS and controls revealed more intense staining in low-grade MDS samples. The quantification of p-p38 staining was analyzed by counting the total number of positively stained cells (B) and by measuring intensity of the positively stained cells (C) in 5 hot fields (defined as area of high density of p-p38 staining) and aided by Image Pro Plus software. Error bars indicate SEM. Two-tailed t test shows significantly higher p38 activation per hot field in low-grade MDS samples. Differences in total p38 MAPK protein expression in 5 representative samples from each group were also evaluated in MDS and control bone marrows by immunostaining with an antibody against p38 MAPK (D).

Close Modal

or Create an Account

Close Modal
Close Modal